Catherine Sohn

Catherine Sohn

Directeur/Membre du Conseil chez ALTIMMUNE, INC.

Fortune : 4 575 $ au 31/05/2026

72 ans
Health Technology
Commercial Services
Consumer Services

Profil

Catherine Angell Sohn was the founder of Sohn Health Strategies LLC, founded in 2010, serving as President.
Current jobs include Non-Executive Chairman at BioEclipse Therapeutics, Inc. since 2016; Director at Jazz Pharmaceuticals, Inc. since 2012; Director at World Affairs Council of Philadelphia; Director at Eversana Life Science Services LLC; Director at Dohmen Co. since 2012; Director at Ariel Pharmaceuticals, Inc.; Independent Director at Altimmune, Inc. since 2023; and Professor at the University of the Sciences in Philadelphia since 2013.
Former jobs include Chairman at Eclipse Therapeutics, Inc.; Independent Director at Lifecore Biomedical, Inc. from 2012 to 2022; Director at Healthcare Businesswomens Association; Independent Director at Seneca Biopharma, Inc. from 2014 to 2017; Director at Consumer Healthcare Products Association; Independent Director at Axcella Health, Inc. from 2019 to 2023; Independent Director at Rubius Therapeutics, Inc. from 2018 to 2023; Director at World Self-Medication Industry Association; Independent Director at Jazz Pharmaceuticals Plc from 2012 to 2024; Independent Director at Maze Therapeutics, Inc. from 2021 to 2026; Director at Armis Biopharma, Inc.; Senior Vice President at GSK Plc from 2003 to 2010; Adjunct Professor at The University of California, San Francisco; Senior Vice President-Business Development at Haleon US LP from 1998 to 2010; Senior Vice President-Worldwide Business at GlaxoSmithKline LLC; VP-Worldwide Strategic Product Development at Smithkline Beecham Pharmaceuticals Ltd. from 1994 to 1998; Trustee at Licensing Executives Society USA & Canada, Inc. from 2008 to 2011; and Professor at Philadelphia College of Pharmacy from 1978 to 1982.
Education includes a doctorate from The University of California, San Francisco, conferred in 1977.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/05/2026 1 500 ( 0% ) 4 575 $ 31/05/2026
-.--%
31/03/2026 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Catherine Sohn

SociétésPosteDébut
ALTIMMUNE, INC. Directeur/Membre du Conseil 23/03/2023
Directeur/Membre du Conseil 01/01/2012
Président 01/08/2016
Directeur/Membre du Conseil -
Corporate Officer/Principal -
World Affairs Council of Philadelphia
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/01/2012
Directeur/Membre du Conseil -

Anciens postes connus de Catherine Sohn

SociétésPosteFin
Directeur/Membre du Conseil 08/06/2026
░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Catherine Sohn

Formation de Catherine Sohn

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

83

Relations au 1er degré

27

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées27

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

World Affairs Council of Philadelphia

Commercial Services

Commercial Services

Health Technology

Health Technology

Smithkline Beecham Pharmaceuticals Ltd.

Commercial Services

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Catherine Sohn
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT